Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
2 search results for:

478 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 06-26-2021 | ADA 2021 | News | Article

    SURPASS-1: Tirzepatide has ‘potent’ glucose-lowering and weight loss efficacy

    SURPASS-1 tested tirzepatide against placebo in 478 people (average age 54 years, 48% women) with uncontrolled type 2 diabetes, who had never used injectable diabetes medications and had not used oral ones within the 3 months prior to baseline.

    Author:
    Eleanor McDermid
    Published in:
    ADA Scientific Sessions; 25–29 June 2021 Lancet 2021; doi:10.1016/S0140-6736(21)01324-6 Lancet 2021; doi:10.1016/S0140-6736(21)01390-8
  2. 08-09-2019 | Insulin | News | Article

    Weight loss differences seen with fixed vs flexible insulin, GLP-1RA regimens

    The retrospective study included data for 609 patients on basal insulin for type 2 diabetes who initiated a fixed (n=131) or flexible (n=478) basal insulin/GLP‐1RA combination between 2010 and 2018.

    Published in:
    Diabet Obes Metab 2019; doi:10.1111/dom.13840
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.